We are live on ! Find out more
LSTA icon

Lisata Therapeutics
LSTA

58 hedge funds and large institutions have $21M invested in Lisata Therapeutics in 2014 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 18 increasing their positions, 6 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

286% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 7

200% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 6

67% more capital invested

Capital invested by funds: $12.6M → $21M (+$8.41M)

53% more funds holding

Funds holding: 38 → 58 (+20)

42% less call options, than puts

Call options by funds: $793K | Put options by funds: $1.38M

Holders
58
Holders Change
+20
Holders Change %
+52.63%
% of All Funds
1.67%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
27
Increased
18
Reduced
6
Closed
7
Calls
$793K
Puts
$1.38M
Net Calls
-$586K
Net Calls Change
+$230K

Top Buyers

Rank Fund Capital Flow
1
BFA
BlackRock Fund Advisors
California
+$3.8M
2
PRCM
Pine River Capital Management
Minnesota
+$3.44M
3
BIT
BlackRock Institutional Trust
California
+$1.36M
4
State Street
State Street
Massachusetts
+$1.23M
5
TCIM
TIAA CREF Investment Management
New York
+$633K

Top Sellers

Rank Fund Capital Flow
1
IHM
Iguana Healthcare Management
New York
-$1.41M
2
U
UBS
Switzerland
-$364K
3
DC
Deere & Company
Illinois
-$325K
4
LP
LMR Partners
United Kingdom
-$162K
5
Morgan Stanley
Morgan Stanley
New York
-$150K
Name Holding Trade Value Shares
Change 		Change in
Stake
PAM
51
Panagora Asset Management
Massachusetts
$13K +$12.6K +13 New
VFA
52
Virtus Fund Advisers
Connecticut
$13K +$12.6K +13 New
Wells Fargo
53
Wells Fargo
California
$12K -$36.9K -38 -76%
HFM
54
Hartford Financial Management
Connecticut
$11K +$10.7K +11 New
JIC
55
Joel Isaacson & Co
New York
$10K – – –
DADC
56
D.A. Davidson & Co
Montana
$2K +$2.92K +3 New
Ameriprise
57
Ameriprise
Minnesota
$1K – – –
IHM
58
Iguana Healthcare Management
New York
– -$1.41M -1,333 Closed
DC
59
Deere & Company
Illinois
– -$325K -307 Closed
LP
60
LMR Partners
United Kingdom
– -$162K -153 Closed
BCMU
61
BlueCrest Capital Management (UK)
Guernsey
– -$115K -109 Closed
JP Morgan Chase
62
JP Morgan Chase
New York
– -$95K -90 Closed
Citadel Advisors
63
Citadel Advisors
Florida
– -$86.5K -89 Closed
BG
64
BlackRock Group
United Kingdom
– -$43K -41 Closed
Deutsche Bank
65
Deutsche Bank
Germany
– +$972 +1 New
1 2
3

LSTA Hedge Fund Activity: Q2 2014 in Review

58 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Lisata Therapeutics (LSTA) for Q2 2014, worth a combined $21M — up 67% from $12.6M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new LSTA positions and 7 closed out — a net gain of 20 holders — while 18 added to existing stakes and 6 trimmed.

The largest buyer was BlackRock Fund Advisors, opening a new position worth an estimated $3.8M. The largest seller was Iguana Healthcare Management, exiting entirely with an estimated $1.41M sold.

  • 58 institutional investors held Lisata Therapeutics (LSTA) as of Q2 2014, up from 38 in Q1 2014.
  • Funds reported $21M of Lisata Therapeutics stock for Q2 2014, up 67% quarter-over-quarter.
  • 27 funds opened new Lisata Therapeutics positions in Q2 2014 and 7 closed out, a net change of +20 holders.
  • The largest Lisata Therapeutics buyer in Q2 2014 was BlackRock Fund Advisors, an estimated $3.8M added.
  • The largest Lisata Therapeutics seller in Q2 2014 was Iguana Healthcare Management, an estimated $1.41M sold.

Based on aggregated 13F filings for Q2 2014.